Recent research reveals a notable association between vitamin D levels and the severity of negative symptoms in individuals with first-episode psychosis (FEP). A new study explored the genetic predisposition towards lower vitamin D levels and its impact on symptom severity in schizophrenia and related disorders. Highlights: Vitamin D & Psychosis Connection: Lower levels of vitamin …
Phentermine is an anorectic medication utilized principally for the short-term treatment of obesity as an adjunct to caloric restriction, dietary modifications, and physical exercise. It is formally classified as a psychostimulant due to the fact that it increases mental and physical arousal [via sympathomimetic mechanisms]. Specifically, phentermine facilitates central and peripheral catecholamine release (primarily of …
Vyvanse (Lisdexamfetamine) is a drug developed by Shire Pharmaceuticals as a successor to Adderall. Vyvanse was first approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 2007. In 2015, Vyvanse was approved for binge eating disorder and was found to successfully minimize appetite and number of binge eating episodes per week compared to a placebo. …
Most people have heard of the neurotransmitter dopamine and understand that it’s release is associated with feelings of pleasure and reward. Dopamine functions as a neurotransmitter that plays a major role in reward and motivation behavior. Most rewards such as: food, sex, drugs, etc. are all capable of increasing the level of dopamine in the …
Provigil (Modafinil) is a drug classified as a “eugeroic” or wakefulness promoting agent. It is considered one of the most effective medications in treating shift work sleep disorder, narcolepsy, and excessive daytime sleepiness as a result of sleep apnea. Many people have also used this medication on an off-label basis for the treatment of depression, …
Strattera (Atomoxetine) is a relatively well-known NRI (norepinephrine reuptake inhibitor) that is commonly used for the treatment of ADHD. Its mechanism of action involves inhibiting the reuptake of the neurotransmitter norepinephrine, thereby increasing extracellular levels. This tends to result in a stimulating effect, which boosts overall cortical activity and helps improve cognitive function among those …
Vyvanse (Lisdexamfetamine) is a psychostimulant medication that was developed by the company Shire. It is primarily prescribed for the treatment of ADHD (attention deficit hyperactivity disorder) and works well to improve cognitive function. In addition to treating ADHD, many doctors have used the drug to help individuals with excessive daytime sleepiness and binge eating disorders. …